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j Abstract Background Psychiatric epidemiological
surveys in developing countries are rare and are fre-
quently conducted in regions that are not necessarily
representative of the entire country. In addition, in
large countries with dispersed populations national
rates may have low value for estimating the need for
mental health services and programs. Methods The
Chile Psychiatric Prevalence Study using the Com-
posite International Diagnostic Interview was con-
ducted in four distinct regions of the country on a
stratiﬁed random sample of 2,978 people. Lifetime
and 12-month prevalence and service utilization rates
were estimated. Results Signiﬁcant differences in the
rates of major depressive disorder, substance abuse
disorders, non-affective psychosis, and service utili-
zation were found across the regions. The differential
prevalence rates could not be accounted by socio-
demographic differences between sites. Conclu-
sions Regional differences across countries may exist
that have both implications for prevalence rates and
service utilization. Planning mental health services for
population centers that span wide geographical areas
based on studies conducted in a single region may be
misleading, and may result in areas with high need
being underserved.
j Key words community prevalences – psychiatric
disorders – regional differences – Chile
Cross-national psychiatric epidemiological prevalence
studies using similar diagnostic instruments have
resulted in disparate rates for speciﬁc disorders [1].
The reasons for these differences in rates have been
attributed to methodological issues between studies;
socio-demographic factors such as socio-economic
status differences between countries; and cultural
differences. Cross-national comparative studies [2, 3]
attempt to correct for socio-demographic variability;
yet, differences persist. In some regions of the world,
such as prevalence rates in Chinese based studies [4–
6], the rates are markedly different than the rest of the
world. This either suggests true differences in the
rates of pathology or lack of cultural appropriateness
of the diagnostic tools and the Western diagnostic
systems utilized [7]. Understanding these cross-na-
tional differences may provide clues into the etiology
of psychopathology.
Regional differences also exist within countries as
evidenced by studies where the methodology is sim-
ilar across geographic areas [8–11]. Regional differ-
ences in the presence of serious mental illness have
been attributed to migration of the mentally ill [12,
13]; birth in urban areas [14]; and genetic pooling
[15]. The most studied regional differences are those
between urban and rural populations, where urban
environmental adversity is argued to contribute to
pathology [16, 17].
An understanding of regional differences in
countries where the population is spread across large
distances is relevant for health care planning. Poten-
tially risk factors may differ across a country resulting
in the need to address mental health needs on a re-
gional basis rather than centrally. Furthermore, an
understanding of geographic variability permits allo-
cation of resources to be distributed in a proportional
basis by need.
This issue is of particular importance to develop-
ing countries such as in Latin America, where fre-
quently services are only provided centrally, or
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4disproportionately to the wealthier regions of a
country. In addition, epidemiological studies based
on single regions of the country [18–20] are extrap-
olated to larger population bases for which they may
or may not be representative.
Population studies about psychiatric disorders in
Latin America, as well as other developing regions of
the world, are rare. They are important, however, for
understanding variations in patterns of disorders,
underlying determinants, and service needs. Chile,
given its rather extraordinary geography provides an
important test of variations in disorder rates across a
spatially dispersed population, and offers perhaps the
best case example of a country where national rates
would seemingly have low value for estimating the
need for mental health services and programs.
The Chile Psychiatric Prevalence Study (CPPS) was
developed to address issues regarding the prevalence
and risk factors for mental illness based on a
nationally representative sample, and service utiliza-
tion. Chile has a population of approximately
16 millions people. The country is composed of 51
provinces grouped in 13 regions covering an area
spanning 2 million km
2 (including Antarctica and
Insular Territories) over a length of 8,000 km. The
large distances between major population centers re-
sulted in the CPPS being conducted in four regions of
the country, Bio Bio, the south-central region con-
taining the second largest city, Metropolitana, the
north-central region which includes the capital San-
tiago, Tarapaca, the north, and Araucania, the south
of the country, in order to obtain a representative
sampling of the population of the nation. This report
focuses on whether regional differences in the prev-
alence of psychiatric disorders and service utilization,
if present, are due to factors other than socio-demo-
graphic differences between population centers.
Methods
j Sample selection
The CPPS was based on a household stratiﬁed sample of people age
15 and older. A more detailed description of the methods used in
the CPPS is available in earlier publications [21]. The sample frame
was developed to be representative of the nation’s population. Four
regions and their most representative province and comunas were
selected. These were subsequently subdivided into districts, and
then randomly selected blocks. The number of households available
on each block was enumerated. The 1992 census of each region was
used to determine the number of households required on each
block. A list of the inhabitants, age 15 and older, in each household
was generated. Using pre-assigned Kish tables (Kish 1965) one
person per household was selected from the list to be interviewed.
The survey was conducted by the University of Concepcion,
Department of Psychiatry and Mental Health, between July 1992
and June 1999, with each site being completed in the following
order based on funding: Bio Bio, Metropolitana, Tarapaca, and
Araucania. A total of 2,987 individuals participated in the survey.
Response rate did differ by site (v
2 = 11.08, df = 3, P < 0.02) with
Metropolitana having the highest non-response rate 12.6% and
Tarapaca the lowest 7.5%. A weight was used to account for the
probability of the comuna, district, block, household, and respon-
dent being selected. The data was adjusted to the 1992 census of
each region based on age, gender, and marital status using a second
weight.
j Diagnostic assessment
Composite International Diagnostic Interview (CIDI) versions 1.0
and 1.1 [22] were used to generate the diagnoses using well-trained
lay interviewers. DSM-III-R [23] diagnostic criteria were employed.
A section on health service utilization in the 6-months prior to the
interview was also included. The Spanish translation was conducted
using the protocol outlined by the World Health Organization
(WHO) [24]. A validation study of the Chilean CIDI was found to
have kappas that ranged from 0.52 for somatiform disorders up to
0.94 for affective disorders [25] using a sample of patients and
volunteers for each CIDI section. After double entry of data and
veriﬁcation for logical inconsistencies diagnoses were generated
using the CIDI computer programs for 1.0 and 1.1 [26]. The DSM-
III-R diagnoses included in this report are all affective disorders; all
anxiety disorders deﬁned as panic disorder, agoraphobia, and
generalized anxiety disorder; substance use disorder which does not
include nicotine dependence, and any diagnosis. Lifetime and 12-
month prevalence rates were examined.
j Interviewers and training
Social science university students in their senior year underwent
training following the WHO protocol at the University of Concep-
cion,a WHOCIDItrainingandreferencecenter.The64interviewers
received over 80 h of instruction and practice sessions. Each inter-
viewer had to conduct practice interviews with volunteer adult sub-
jects with and without psychiatric disorders selected from local
clinics, as well as a pilot interview on an individual in a non-selected
household in the community. Approximately 80% of the interviews
were audiotaped following the subject’s consent, and 20% randomly
reviewed for quality control.
j Analysis procedures
The SUDAAN statistical package [27], Taylor series linearization
method, was used to estimate the standard errors due to the sample
design and the need for weighting. The analysis was conducted
using procedures without replacement for non-respondents. The
comuna and district selected were used as the deﬁned strata. Chi-
square analyses were used to examine the association of disorders
and service utilization between regions. Logistic regression was
used to adjust for socio-demographic differences across regions
accounting for differential rates or service utilization. Additional
analyses were conducted to examine urban–rural differences. The
logistic regression analyses included gender, marital status, age
group, education, and income as potential confounders. All results
are presented as weighted data.
Results
The distribution of income and marital status were
found to differ across the four regions of the country
(see Table 1). The population of Bio Bio had signiﬁ-
cantly lower incomes than the other regions
(v
2 = 67.96, df = 9, P < 0.0001). In addition, Bio Bio
had the lowest rate of individuals who were separated
or had annulled marriages (v
2 = 25.31, df = 12,
P < 0.05). In two of the regions the rural population
was under-represented relative to the census. In Bio
936Bio 22% of population was rural the sample only in-
cluded 2.7%, and in Araucania 38% of the population
was rural and the sample only included 7.7%.
Prior to adjusting for socio-demographic differ-
ences between the regions, a number of differences in
prevalence rates were noted (see Tables 2, 3). Lifetime
rates for major depressive disorder were markedly
elevated in Tarapaca, 17.2%, and lowest in Bio Bio,
11.6% (v
2 = 9.76, df = 3, P < 0.04). Drug abuse, but
not dependence, also had the highest prevalence rate
in Tarapaca, 2.4% (v
2 = 8.59, df = 3, P < 0.05).
Interestingly, in Araucania the rate of non-affective
psychosis was the lowest (v
2 = 11.45, df = 3,
P < 0.02). When females were examined the differ-
ential rates for major depressive disorder (v
2 = 11.76,
df = 3, P < 0.02) and substance use disorders were
noted (v
2 = 10.88, df = 3, P < 0.03). Among males
the only lifetime difference in prevalence rates was for
elevated alcohol abuse in Tarapaca (v
2 = 9.17, df = 3,
P < 0.04). For 12-month prevalence the increased risk
for major depression in Tarapaca persisted (v
2 = 8.78,
df = 3, P < 0.05) for both genders combined and for
females (v
2 = 10.08, df = 3, P < 0.03). The differences
noted in the prevalence of substance use disorders
were no longer evident at 12-months.
Using logistic regression controlling for socio-
demographic variables the regional differences for
major depression were maintained for both lifetime
and 12-month prevalence, as well as among females in
both prevalence periods. Males with lifetime prevalent
affective disorders were also at increased risk in
Tarapaca. In addition regional differences in lifetime
prevalence for alcohol abuse, drug abuse, and nicotine
dependence were found. Among females, regional
differences in lifetime prevalence were noted for drug
abuse, drug dependence, any alcohol or drug use
disorder, and cognitive disorders, and among men
alcohol abuse with increased risk among those
residing in Tarapaca. The statistical differences in
regional lifetime prevalence of non-affective psychosis
for both genders combined, and females in both
prevalence periods, persisted with the rates for Ar-
aucania remaining low. As the rates for not only
major depression, but also alcohol and drug use dis-
orders were elevated in Tarapaca, additional analyses
were conducted controlling for comorbidity in the
logistic regressions, the regional differences noted
were not altered.
Differences in service utilization across the four
regions were also found. Araucania had the lowest use
of mental health services utilization (v
2 = 0.03,
df = 3, P < 0.03), in particular in the non-specialized
health care sector (v
2 = 12.63, df = 3, P < 0.02). The
rates of service utilization by region are presented in
Table 1 Socio-demographic characteristics by region
Bio Bio
(N = 800)
Metropolitana
(N = 1363)
Tarapaca
(N = 306)
Araucania
(N = 509)
Disorders %S E %S E %S E %S E v
2 df P
Gender
Male 48.2 1.0 46.4 1.4 48.9 1.0 47.4 1.5 3.23 3 0.38
Female 51.8 1.0 53.6 1.4 51.1 1.0 52.6 1.5
Age
15–24 26.7 1.6 24.9 2.1 27.3 2.3 27.0 7.4 7.3 15 0.94
25–34 25.4 1.6 26.1 1.4 27.1 0.6 23.2 4.6
35–44 18.2 1.9 18.5 1.1 21.1 2.0 17.5 2.6
45–54 12.1 1.4 12.8 1.2 11.8 0.4 12.3 1.2
55–64 9.0 1.4 9.2 0.8 6.5 0.4 9.8 1.3
65+ 8.7 2.3 8.5 1.0 6.2 1.9 10.4 1.7
Education
No education 2.7 1.0 1.1 0.2 0.3 0.2 1.3 1.0 11.13 9 0.31
Basic 19.7 3.8 17.9 2.3 7.8 2.0 15.2 7.6
Medium 52.3 3.3 47.9 1.6 52.7 1.5 38.2 7.3
High 25.2 7.1 33.2 2.3 39.1 3.2 45.2 15.4
Marital status
Married 54.7 2.8 52.8 2.3 53.7 3.2 52.3 5.8 25.31 12 0.05
Widowed 5.2 1.1 4.7 0.7 3.3 1.3 5.8 0.2
Separated/anulled 1.7 0.7 4.1 0.5 3.3 1.4 2.0 0.6
Never Married 34.4 1.9 32.6 2.4 33.9 1.1 36.1 8.0
Common Law 4.0 0.8 5.8 1.0 5.9 0.6 3.8 2.0
Income
U$100–U$400 70.5 7.1 54.5 3.9 12.2 4.8 47.7 15.4 67.96 9 0.0001
U$401–U$800 19.3 3.3 21.9 1.8 29.6 2.5 20.6 4.5
U$801–U$1500 6.9 1.9 11.9 1.3 35.6 3.3 12.5 4.0
U$1501+ 3.3 2.5 11.7 2.8 22.7 3.6 19.2 7.2
Urban/rural
Urban 97.3 3.1 99.2 0.9 98.9 1.4 92.3 5.0 3.1 3 0.39
Rural 2.7 3.1 0.8 0.9 1.1 1.4 7.7 5.0
937Table 2 Lifetime prevalence rates of DSM-III-R disorders by region
Bio Bio Metropolitana Tarapaca Araucania
Disorders %S E %S E %S E %S E v
2 P
Affective disorders
Major depressive episode 7.1 1.3 11.6 0.8 17.2 2.4 9.8 0.8 9.76 0.04
Manic episode 2.2 0.7 1.4 0.4 1.8 0.3 1.5 1.3 1.11 0.78
Dysthmia 7.5 1.1 7.3 1.2 12.2 1.7 6.0 3.3 3.65 0.32
Any affective disorder 13.6 2.2 15.4 1.2 23.2 1.9 14.0 3.2 3.88 0.30
Anxiety disorders
Panic disorder 1.2 0.6 1.3 0.3 4.3 0.8 1.1 0.5 1.16 0.77
Agoraphobia without panic 14.2 2.7 9.8 1.3 9.7 1.8 5.3 0.8 5.46 0.16
Generalized anxiety disorder 1.8 0.7 3.7 0.5 2.0 0.4 3.0 0.6 5.13 0.19
Any anxiety disorder 19.2 3.7 14.8 1.6 17.9 1.7 8.6 0.9 6.79 0.11
Substance use disorders
Alcohol abuse 2.8 0.8 2.0 0.5 16.9 2.6 7.2 1.4 8.20 0.06
Alcohol dependence 7.0 1.7 6.4 0.8 6.3 0.5 5.0 0.8 3.63 0.32
Drug abuse 0.6 0.3 1.5 0.4 2.4 0.5 0.1 0.1 8.59 0.05
Drug dependence 2.2 0.7 3.3 1.0 2.2 0.3 1.2 0.1 7.72 0.07
Nicotine dependence 2.9 0.6 2.1 0.6 6.5 0.2 5.4 1.0 7.86 0.07
Any alcohol or drug use disorder 11.0 1.8 11.2 1.0 24.3 2.9 12.3 1.8 1.94 0.59
Any substance use disorder 13.0 2.0 12.9 1.1 29.6 2.9 14.6 1.7 2.43 0.50
Other disorders
Non-affective psychosis 2.1 0.6 2.3 0.5 0.8 0.2 0.1 0.0 11.45 0.02
Somatoform disorder 2.7 1.1 4.4 0.8 3.1 0.6 3.5 0.7 1.75 0.63
Cognitive disorder 4.5 1.8 3.7 0.8 0.7 0.8 1.0 0.4 5.70 0.15
Any CPPS disorder 32.2 4.1 30.8 1.6 44.4 1.9 28.9 3.1 2.51 0.49
Female
Affective disorders
Major depressive episode 7.1 1.3 15.2 1.4 20.6 0.8 11.2 1.1 11.76 0.02
Manic episode 2.6 1.0 1.8 0.5 3.0 0.6 0.5 0.5 3.62 0.32
Dysthmia 10.7 2.0 11.6 1.9 17.2 1.3 8.7 5.1 2.43 0.50
Any affective disorder 16.4 2.6 21.0 1.7 28.3 0.9 16.0 4.9 3.60 0.32
Anxiety disorders
Panic disorder 1.7 0.9 2.1 0.5 6.7 1.2 2.1 0.9 1.15 0.77
Agoraphobia without panic 20.3 3.2 13.6 2.0 12.2 0.2 7.0 2.4 4.88 0.20
Generalized anxiety disorder 2.5 1.0 6.4 1.0 3.8 0.8 4.4 0.4 5.98 0.13
Any anxiety disorder 26.4 3.9 20.9 2.5 24.8 2.1 12.3 2.0 5.19 0.18
Substance use disorders
Alcohol abuse 0.5 0.4 1.1 0.6 2.6 0.4 1.0 0.4 2.06 0.57
Alcohol dependence 1.7 0.7 2.0 0.7 4.2 0.2 0.4 0.2 7.53 0.07
Drug abuse 0.0 0.0 0.8 0.3 2.3 0.5 0.0 0.0 7.38 0.08
Drug dependence 2.4 0.7 5.0 1.6 2.7 0.4 0.2 0.2 6.86 0.10
Nicotine dependence 2.5 0.7 2.3 0.8 10.0 0.6 2.6 0.4 2.45 0.49
Any alcohol or drug use disorder 3.6 0.9 7.1 1.5 6.9 0.6 1.6 0.6 11.80 0.02
Any substance use disorder 5.9 1.4 8.9 1.4 16.5 0.3 4.1 0.7 10.88 0.02
Other disorders
Non-affective psychosis 2.4 0.7 1.9 0.6 1.6 0.3 0.1 0.1 7.81 0.07
Somatoform disorder 2.4 0.7 5.3 1.1 3.6 0.7 4.4 1.7 4.10 0.27
Any CPPS disorder 35.6 3.8 34.7 2.5 37.8 1.1 23.4 4.0 3.02 0.40
Male
Affective disorders
Major depressive episode 7.1 1.5 7.4 1.3 13.6 4.6 8.3 1.5 6.84 0.10
Manic episode 1.8 1.0 1.0 0.4 0.5 0.6 2.6 2.2 1.18 0.76
Dysthmia 4.0 1.0 2.4 0.6 7.1 3.3 3.1 2.0 4.10 0.27
Any affective disorder 10.5 2.2 9.0 1.4 18.0 4.3 11.8 2.9 14.57 0.01
Anxiety disorders
Panic disorder 0.7 0.5 0.4 0.2 1.8 0.3 0.0 0.0 4.39 0.24
Agoraphobia without panic 7.7 2.9 5.3 1.9 7.2 3.5 3.5 1.0 3.94 0.28
Generalized anxiety disorder 1.0 0.7 0.7 0.4 0.0 0.0 1.3 1.0 1.83 0.61
Any anxiety disorder 11.5 4.4 7.9 1.7 10.6 3.4 4.5 0.5 7.59 0.07
Substance use disorders
Alcohol abuse 5.3 1.5 3.0 0.8 31.9 5.6 14.1 2.8 9.17 0.04
Alcohol dependence 12.5 3.7 11.6 1.9 8.4 1.2 10.2 1.8 1.11 0.77
Drug abuse 1.1 0.7 2.4 0.8 2.6 0.6 0.2 0.2 6.93 0.09
Drug dependence 1.9 1.1 1.5 0.6 1.6 0.4 2.3 0.5 1.40 0.71
Nicotine dependence 3.2 0.7 1.9 0.9 2.9 0.5 8.6 2.2 6.05 0.13
Any alcohol or drug use disorder 18.9 4.1 15.9 1.9 42.6 6.3 24.3 3.4 4.83 0.20
Any substance use disorder 20.5 4.3 17.6 2.1 43.3 5.8 26.2 2.9 5.55 0.16
(Continued)
938Table 4. The lower use of services persisted after
controlling for socio-demographic variables in a lo-
gistic regression.
When urban versus rural was examined across all
sites no statistical differences in the rates of disorders
were noted. In addition, there were no socio-demo-
graphic differences. The sample size of the rural
population was small, 203.
Discussion
Regional differences that persisted after adjusting for
potential confounders persisted in the CPPS. Major
depression and substance use disorders were highly
prevalent in Tarapaca. The high rates of substance use
disorders, especially drugs, and were not surprising as
the region bordering Bolivia and Peru is heavily in-
volved in the drug trade. The increased rates of major
depression, however, could not be accounted for by
substanceusedisordercomorbidity.Thedifferencesin
rates for non-affective psychosis, although may simply
be due to a type 1 error, are nonetheless surprising as
the Araucania region’s population and our sample has
a sizable proportion of Mapuche indigenous people.
The Mapuche in earlier psychiatric literature were
thought to be at increased risk for psychosis [28]. The
small sample size of the rural population precluded
ﬁnding statistically signiﬁcant differences.
The utilization of health service was lowest in Ar-
aucania and Bio Bio. This may be consistent with the
inequities in availability and access that do exist in
health and mental health resources across different
regionsofChile.Thesouthernhalfofthecountryisthe
poorestandhastheleastresources;therefore,thelower
ratesmaybeduetoalackofaccessratherthandemand.
Forexampleacrosstheregionsthenumberofavailable
mentalhealthbeds2001inthepublichealthserviceper
100,000 were Araucania 2.2; Bio Bio 4.8; Metropolitana
34.2; and Tarapaca 47.2. The number of primary care
physicians per 100,000 populations also was lowest in
Araucania, 57.0, compared to Bio Bio with 169.7,
Tarapaca with 61.6 and Metropolitana with 185.8.
It could be argued that these regional differences
are simply artifact due to sampling differences.
Clearly the population investigated in Tarapaca is
small for a prevalence study and may have resulted in
rates that may prove unstable. Another potential
limitation is that the four regions were investigated
sequentially, with the potential for socio-cultural
inﬂuences to impact on the rates during the intervals
between data collection. The high proportion of low-
income individuals in the Bio Bio sample in com-
parison to the other sites and in particular Aracuca-
nia, the poorest region of the country, reﬂects the
improved economic conditions in Chile during the
course of data collection and supports a cohort effect.
A cohort effect, however, is highly unlikely to explain
the rates of psychopathology given that data collec-
tion was obtained from Araucania last, yet it has the
highest rate of major depressive disorder.
Conclusion
Regional differences across countries may exist that
have both implications for prevalence rates and ser-
vice utilization. Planning mental health services for
population centers that span wide geographical areas
based on studies conducted in a single region may be
misleading, and may result in areas with high need
being underserved. Psychiatric epidemiological stud-
ies that are nationally representative of developing
nations are needed that have a sufﬁcient sampling
frame to examine populations believed to be at high
risk and regions where increased inequities may exist.
Even the most recent epidemiological studies repre-
senting Latin America [6, 29] have ignored large
segments of the population, such as those countries
and regions of countries with large indigenous pop-
ulations or segments of the population that are very
poor. Fewer studies in the region have examined
service needs and none have addressed regional dif-
ferences in services. Data that is more representative
of the Latin American population is needed in order
to improve mental health services planning and
addresses the large under-estimated treatment gap.
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Table 2 Continued
Bio Bio Metropolitana Tarapaca Araucania
Disorders %S E %S E %S E %S E v
2 P
Other disorders
Non-affective psychosis 1.8 1.1 2.7 1.1 0.0 0.0 0.0 0.0 5.78 0.14
Somatoform disorder 3.0 1.7 3.2 1.3 2.6 0.5 2.6 0.9 0.23 0.97
Any CPPS disorder 28.5 5.3 26.4 2.3 51.2 4.0 35.0 5.0 4.46 0.23
Non-affective psychosis includes schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, and atypical psychosis
Any CPSS disorder does not include nicotine dependence or cognitive disorder; v
2 df = 3
939Table 3 12-Month prevalence rates of DSM-III-R disorders by region
Bio Bio Metropolitana Tarapaca Araucania
Disorders %S E %S E %S E %S E v
2 P
Total
Affective disorders
Major depressive episode 4.1 0.9 7.8 0.8 10.3 1.9 5.1 1.1 8.78 0.05
Manic episode 1.9 0.7 1.1 0.3 1.8 0.3 1.0 0.9 2.05 0.57
Dysthmia 3.0 0.7 4.1 1.2 7.9 2.2 3.1 2.2 6.10 0.13
Any affective disorder 7.8 1.6 10.8 1.3 15.0 1.6 7.5 2.9 5.19 0.18
Anxiety disorders
Panic disorder 0.5 0.3 0.4 0.2 4.1 0.9 0.6 0.6 1.32 0.73
Agoraphobia without panic 7.0 1.8 6.1 1.5 7.5 2.0 2.2 0.9 4.44 0.24
Generalized anxiety disorder 1.2 0.5 2.3 0.6 1.1 0.3 1.7 0.5 2.41 0.50
Any anxiety disorder 11.1 1.7 9.2 1.6 11.9 1.6 3.8 1.3 5.69 0.15
Substance use disorders
Alcohol abuse 2.1 0.6 1.8 0.5 5.8 1.8 3.3 0.8 4.05 0.28
Alcohol dependence 5.2 1.5 4.8 0.7 3.7 0.4 2.8 0.5 4.26 0.26
Drug abuse 0.2 0.2 0.4 0.2 1.5 0.4 0.0 0.0 3.99 0.28
Drug dependence 1.5 0.8 1.9 0.5 1.8 0.3 0.4 0.4 2.91 0.42
Nicotine dependence 2.1 0.5 1.9 0.6 5.6 0.3 4.4 1.0 4.18 0.26
Any alcohol or drug use disorder 8.4 1.6 7.9 0.9 10.7 2.0 6.2 1.2 2.84 0.43
Any substance use disorder 10.0 1.6 9.4 1.0 15.7 2.1 8.2 1.6 2.38 0.51
Other disorders
Non-affective psychosis 1.1 0.4 1.4 0.3 0.8 0.2 0.0 0.0 8.45 0.06
Somatoform disorder 1.8 0.8 3.9 0.6 3.1 0.6 3.0 0.6 2.95 0.42
Any CPPS disorder 23.9 3.5 23.0 1.5 25.3 1.7 14.7 3.9 2.84 0.43
Female
Affective disorders
Major depressive episode 4.8 0.9 10.5 1.3 14.8 0.8 5.3 2.4 10.08 0.03
Manic episode 2.6 1.0 1.5 0.5 3.0 0.6 0.2 0.2 6.25 0.12
Dysthmia 4.3 1.4 6.9 2.3 8.8 1.7 3.9 3.2 6.92 0.09
Any affective disorder 9.6 1.8 15.2 2.2 20.0 0.9 8.2 5.3 5.72 0.15
Anxiety disorders
Panic disorder 0.5 0.3 0.6 0.3 6.6 1.3 1.0 1.2 1.37 0.71
Agoraphobia without panic 11.9 3.0 8.4 2.4 10.4 0.3 3.4 1.0 5.78 0.14
Generalized anxiety disorder 1.4 0.8 3.9 1.0 2.2 0.6 2.7 0.7 3.24 0.37
Any anxiety disorder 17.3 2.3 13.0 2.5 17.5 1.2 6.3 1.7 5.90 0.14
Substance use disorders
Alcohol abuse 0.5 0.4 1.0 0.5 0.9 0.2 0.6 0.5 0.93 0.82
Alcohol dependence 0.9 0.5 1.3 0.7 4.2 0.2 0.0 0.0 5.16 0.18
Drug abuse 0.0 0.0 0.2 0.2 0.5 0.1 0.0 0.0 2.48 0.49
Drug dependence 1.5 0.7 2.9 0.8 2.7 0.5 0.2 0.2 8.50 0.05
Nicotine dependence 2.0 0.7 2.1 0.8 8.5 0.4 2.0 0.8 1.71 0.64
Any alcohol or drug use disorder 2.9 1.0 4.5 0.8 5.1 0.4 0.8 0.7 7.98 0.06
Any substance use disorder 4.9 1.4 6.0 0.6 13.3 0.9 2.8 0.7 14.74 0.01
Other disorders
Non-affective psychosis 1.5 0.7 1.2 0.5 1.6 0.3 0.0 0.0 7.05 0.09
Somatoform disorder 1.9 0.7 5.0 1.1 3.6 0.7 4.2 1.8 4.50 0.23
Any CPPS disorder 23.4 2.7 24.7 2.9 28.4 0.9 12.3 5.1 2.83 0.42
Male
Affective disorders
Major depressive episode 3.4 1.1 4.7 1.1 5.5 3.6 5.0 0.4 1.30 0.73
Manic episode 1.1 0.9 0.7 0.3 0.5 0.6 1.8 1.6 0.68 0.88
Dysthmia 1.6 0.8 0.8 0.3 7.0 3.3 2.1 2.0 4.78 0.21
Any affective disorder 5.9 1.7 5.7 1.1 9.8 2.8 6.7 1.3 4.46 0.23
Anxiety disorders
Panic disorder 0.6 0.4 0.2 0.2 1.6 0.4 0.0 0.0 3.07 0.39
Agoraphobia without panic 1.7 0.9 3.4 1.7 4.5 3.8 0.9 0.9 1.94 0.59
Generalized anxiety disorder 1.0 0.6 0.4 0.2 0.0 0.0 0.5 0.4 1.97 0.58
Any anxiety disorder 4.4 1.8 4.7 1.6 6.1 3.5 1.1 0.9 3.26 0.37
Substance use disorders
Alcohol abuse 3.7 1.2 2.7 0.8 10.9 3.7 6.3 1.2 6.20 0.12
Alcohol dependence 9.7 2.8 8.8 1.8 3.1 1.0 5.9 0.9 3.88 0.29
Drug abuse 0.4 0.4 0.7 0.5 2.6 0.6 0.0 0.0 3.47 0.34
Drug dependence 1.5 1.2 0.8 0.5 0.9 0.2 0.6 0.8 0.33 0.95
Nicotine dependence 2.2 0.7 1.8 0.8 2.5 0.5 7.0 2.0 3.08 0.39
Any alcohol or drug use disorder 14.4 3.2 11.8 2.0 16.6 4.4 12.1 1.6 1.25 0.74
Any substance use disorder 15.4 3.2 13.3 2.1 18.2 4.0 14.1 2.8 1.07 0.78
(Continued)
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